(IBHE) iShares iBonds 2025 Term - Ratings and Ratios
High-Yield Bonds, Investment-Grade Bonds, Corporate Bonds, USD-Denominated Bonds
| Risk via 10d forecast | |
|---|---|
| Volatility | 1.07% |
| Value at Risk 5%th | 1.76% |
| Relative Tail Risk | 0.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.60 |
| Alpha | 0.58 |
| Character TTM | |
|---|---|
| Hurst Exponent | |
| Beta | 0.031 |
| Beta Downside | 0.057 |
| Drawdowns 3y | |
|---|---|
| Max DD | 2.36% |
| Mean DD | 0.20% |
| Median DD | 0.06% |
Description: IBHE iShares iBonds 2025 Term October 23, 2025
The iShares iBonds 2025 Term High Yield and Income ETF (BATS: IBHE) aims to allocate at least 80% of its net assets to the securities that comprise its benchmark index, and a minimum of 90% to U.S. dollar-denominated, taxable, fixed-rate corporate bonds rated BBB or lower that mature between 1 Jan 2025 and 15 Dec 2025.
As of the latest reporting period, IBHE’s weighted-average yield sits near 7.2% and its effective duration is roughly 1.1 years, reflecting the short-term, high-yield focus. The fund’s credit spread over the 2-year Treasury averages about 350 basis points, a level that tends to widen when recession expectations rise or when corporate default rates climb. Because the underlying bonds are fixed-rate, the ETF is relatively insulated from near-term interest-rate hikes but remains sensitive to credit-cycle dynamics, especially in energy and consumer discretionary sectors, which dominate the high-yield space.
For a deeper, data-driven look at how IBHE’s risk-return profile compares to peers, you might explore ValueRay’s analytical dashboards.
IBHE ETF Overview
| Market Cap in USD | 412m |
| Category | Target Maturity |
| TER | 0.35% |
| IPO / Inception | 2019-05-07 |
| Return 12m vs S&P 500 | -7.74% |
| Analyst Rating | - |
IBHE Dividends
| Dividend Yield | 4.80% |
| Yield on Cost 5y | 6.08% |
| Yield CAGR 5y | 2.91% |
| Payout Consistency | 96.0% |
| Payout Ratio | - |
IBHE Growth Ratios
| CAGR 3y | 7.58% |
| CAGR/Max DD Calmar Ratio | 3.21 |
| CAGR/Mean DD Pain Ratio | 38.49 |
| Current Volume | 51.2k |
| Average Volume | 116.6k |
What is the price of IBHE shares?
Over the past week, the price has changed by +0.11%, over one month by +0.38%, over three months by +1.05% and over the past year by +5.09%.
Is iShares iBonds 2025 Term a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBHE is around 23.49 USD . This means that IBHE is currently overvalued and has a potential downside of 1.38%.
Is IBHE a buy, sell or hold?
What are the forecasts/targets for the IBHE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 25.8 | 11.2% |
IBHE Fundamental Data Overview November 11, 2025
Beta = 0.18
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 412.2m USD (412.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 412.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 412.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.68% (E(412.2m)/V(412.2m) * Re(6.68%) + (debt-free company))
Discount Rate = 6.68% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBHE ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle